This article is more than 5 years old. Information may no longer be current.

Samuel Waxman Cancer Research Foundation presents award

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Samuel Waxman Cancer Research Foundation selected Timothy J. Ley, MD, to receive its David T. Workman Memorial Award.

The award, presented every other year, recognizes scientists who develop novel therapies for poorly treatable cancer types

Timothy J. Ley

The foundation an international organization dedicated to curing and preventing cancer chose to honor Ley because of his leadership in developing genome sequencing as a platform to identify new molecular targets for the clinical development of more selective, noncytotoxic treatments for acute myeloid leukemia.

Ley is professor of medicine and genetics within the division of oncology at Washington University Medical School. He is past president of the American Society for Clinical Investigation and a member of the National Cancer Advisory Board.